CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5651.4M
Enterprise Value 3384.3M
Trailing P/E 38.60
Forward P/E 1-9.95
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.25
Price/Book (mrq)22.53
Enterprise Value/Revenue 34.28
Enterprise Value/EBITDA 624.82

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 18.69%
Operating Margin (ttm)16.73%

Management Effectiveness

Return on Assets (ttm)5.42%
Return on Equity (ttm)48.14%

Income Statement

Revenue (ttm)89.9M
Revenue Per Share (ttm)1.84
Quarterly Revenue Growth (yoy)68.10%
Gross Profit (ttm)33M
EBITDA 15.48M
Net Income Avi to Common (ttm)16.8M
Diluted EPS (ttm)0.34
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)182.04M
Total Cash Per Share (mrq)3.61
Total Debt (mrq)14.7M
Total Debt/Equity (mrq)50.87
Current Ratio (mrq)2.69
Book Value Per Share (mrq)0.57

Cash Flow Statement

Operating Cash Flow (ttm)42.18M
Levered Free Cash Flow (ttm)41.29M

Trading Information

Stock Price History

Beta 2.08
52-Week Change 377.34%
S&P500 52-Week Change 317.34%
52 Week High 315.08
52 Week Low 35.42
50-Day Moving Average 311.64
200-Day Moving Average 312.17

Share Statistics

Avg Vol (3 month) 3206.51k
Avg Vol (10 day) 3246.66k
Shares Outstanding 550.38M
Float 23.58M
% Held by Insiders 139.38%
% Held by Institutions 154.73%
Shares Short (Aug 31, 2018) 42.53M
Short Ratio (Aug 31, 2018) 415.7
Short % of Float (Aug 31, 2018) 410.13%
Short % of Shares Outstanding (Aug 31, 2018) 45.02%
Shares Short (prior month Jul 31, 2018) 42.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A